Quinolone Antibacterials -
-40% koodiga BOOKS
Saadetis 12-18 tööpäeva jooksul
30-päevane tagastamisõigus
It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical practice. The modification produced in the quinolone nucleus by introducing a fluorine at the 6-position led to the discovery of the newer fluoroquinolones with enhanced antibacterial activities as compared to nalidixic acid. By now a great deal of preclinical and clinica ... Täielik kirjeldus
Võib-olla meeldib sulle ka
TOP
The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma
-40% koodiga BOOKS
Meie tarnija laos
TOP
No Bad Parts: Healing Trauma and Restoring Wholeness with the Internal Family Systems Model
-40% koodiga BOOKS
Meie tarnija laos
TOP
Maybe You Should Talk to Someone: a therapist, her thearapist, and our lives revealed
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Myth of Normal: Trauma, Illness, and Healing in a Toxic Culture
-40% koodiga BOOKS
Laos
TOP
Oxford Handbook of Clinical Medicine
Peter Hateley, Iain McGurgan, Ian B. Wilkinson, Tim Raine, Dearbhla Kelly, Kate Wiles
-40% koodiga BOOKS
Meie tarnija laos
TOP
Harrison's Principles of Internal Medicine (Vol.1 & Vol.2)
Stephen Hauser, Joseph Loscalzo, Steven Holland, Dan Longo, J. Larry Jameson, Dennis Kasper, Carol Langford, Anthony Fauci
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Checklist Manifesto: How to Get Things Right
-40% koodiga BOOKS
Meie tarnija laos
TOP
How Not To Die: Discover the foods scientifically proven to prevent and reverse disease
-40% koodiga BOOKS
Meie tarnija laos
TOP
Vademecum Metabolicum: Diagnosis and Treatment of Inborn Errors of Metabolism Forword by William L. Nyhan, San Diego, USA
Johannes Zschocke, Georg F. Hoffmann
-40% koodiga BOOKS
Meie tarnija laos
TOP
Cellular and Molecular Immunology
Sarah Henrickson, Abul K. Abbas, Andrew H. Lichtman, Shiv Pillai
-40% koodiga BOOKS
Meie tarnija laos
TOP
Physics, Pharmacology and Physiology for Anaesthetists: Key Concepts for the FRCA
Matthew E. Cross, Emma V. E. Plunkett
-40% koodiga BOOKS
Meie tarnija laos
TOP
Being Mortal: Medicine and What Matters in the End
-40% koodiga BOOKS
Meie tarnija laos
TOP
Pocket Guide to Teaching for Clinical Instructors
-40% koodiga BOOKS
Meie tarnija laos
TOP
Oxford Handbook of Critical Care
Andrew Webb, Mervyn Singer, Alice Carter
-40% koodiga BOOKS
Meie tarnija laos
TOP
The Wills Eye Manual: Print + eBook with Multimedia: Office and Emergency Room Diagnosis and Treatment of Eye Disease
-40% koodiga BOOKS
Meie tarnija laos
TOP
Who Deserves Your Love: How to Create Boundaries to Start, Strengthen or End Any Relationship
-40% koodiga BOOKS
Meie tarnija laos
Kirjeldus
It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical practice. The modification produced in the quinolone nucleus by introducing a fluorine at the 6-position led to the discovery of the newer fluoroquinolones with enhanced antibacterial activities as compared to nalidixic acid. By now a great deal of preclinical and clinical experience has been obtained with these agents. The intense interest in this class of antibacterial agents by chemists, micro biologists, toxicologists, pharmacologists, clinical pharmacologists, and clini cians in various disciplines encouraged us to summarize the information on the history, chemistry, mode of action and in vitro properties, kinetics and efficacy in animals, mechanisms of resistance, toxicity, clinical pharmacology, clinical experience, and future prospects in one volume of the Handbook of Experimental Pharmacology. As this series deals predominantly with "experimental" characteristics of drugs, our volume is dedicated specifically to quinolones and emphasizes principally their preclinical and clinical phar macological characteristics, despite the existence of several summaries on quinolones. The chemistry of the quinolones is described in detail. The chapter on the mode of action of quinolones reports the conclusive evidence that gyrase is the intracellular target of the quinolones; however, another enzyme, topoisomerase IV, may also be a target for quinolones, and the exact mechanisms by which quinolones act bactericidally are far from being understood.
Lisateave
| Kirjastaja | Springer Berlin Heidelberg |
|---|---|
| Series | Handbook of Experimental Pharmacology |
| Väljalaskeaasta | 2012 |
| Kaanetüüp | Pehme kaanega |
| EAN | 9783642803666 |